Ashiq Ali | Oncology | Best Researcher Award

Published on by Global Academic Awards

Dr. Ashiq Ali | Oncology | Best Researcher Award

Dr. Ashiq Ali, Shantou University Medical College, China

Dr. Ashiq Ali is a dedicated postdoctoral fellow at Shantou University Medical College, China, with a strong academic background in Pathology and Immunology. He earned his Ph.D. in Pathology and Immunology from the University of Agriculture Faisalabad. With expertise in cancer epigenetics, immunoproteomics, and molecular diagnostics, he has significantly contributed to vaccine development and probiotic research. His commitment to advancing scientific knowledge is evident through numerous publications and successful research projects. As a passionate educator, Dr. Ali has experience mentoring students and conducting lectures on pathology and clinical diagnostics. His dedication to innovative research and academic excellence makes him a valuable contributor to the global scientific community. πŸ“šπŸ”¬πŸ§¬

Publication Profile

Google Scholar

Education πŸŽ“

Dr. Ashiq Ali pursued his Ph.D. in Pathology and Immunology (2017–2022) from the University of Agriculture Faisalabad, focusing on cancer epigenetics and immunoproteomics. Prior to that, he completed his M.Phil. in Pathology (2014–2016) at the same university, excelling in clinical diagnostics and molecular biology. His academic journey began with a Doctor of Veterinary Medicine (DVM) (2009–2014), where he developed a strong foundation in veterinary pathology, microbiology, and immunology. Throughout his education, Dr. Ali demonstrated exceptional dedication, earning prestigious scholarships and excelling in his research pursuits. His continuous pursuit of knowledge in pathological research and immunological studies highlights his commitment to contributing to the medical and scientific fields. πŸ“˜πŸ§‘β€πŸ”¬πŸ”Ž

Experience πŸ’Ό

Dr. Ashiq Ali is currently a postdoctoral fellow at Shantou University Medical College, China, conducting advanced research in pathology and immunology. From 2018 to 2019, he served as a Teaching Assistant at the University of Agriculture Faisalabad, where he conducted practical and theoretical classes on subjects like General Pathology, Clinical Pathology, and Oncology. Between 2016 and 2020, he contributed as a volunteer research assistant, gaining extensive hands-on experience in molecular diagnostics, PCR, immunohistochemistry, and virus cultivation. His role involved supervising laboratory operations, mentoring students, and conducting detailed investigations into infectious diseases, cancer research, and vaccine development. Dr. Ali’s dynamic experience across teaching, research, and lab management highlights his versatility and dedication to scientific advancements. πŸ§ͺπŸ”ŽπŸ“Š

Awards and Honors πŸ†

Dr. Ashiq Ali’s academic excellence has been recognized through prestigious awards, including a Merit Scholarship during his M.Phil. in Pathology at the University of Agriculture Faisalabad (2014–2016). His exceptional research capabilities earned him the Indigenous Ph.D. Fellowship from the Higher Education Commission (HEC) of Pakistan (2018–2022), supporting his groundbreaking work in cancer epigenetics and immunology. These accolades underscore his academic dedication, research competence, and commitment to scientific growth. His contributions have not only elevated his academic standing but also significantly advanced the field of pathology and immunology. πŸ…πŸ“šπŸ§‘β€πŸ”¬

Research Focus 🧬

Dr. Ashiq Ali’s research centers on cancer epigenetics, immunoproteomics, and molecular diagnostics, with a keen interest in tumor identification, immunohistochemistry, and gene expression analysis. His expertise includes the development of vaccines using plant-based adjuvants, investigating the therapeutic potential of interferon-alpha against viruses, and applying probiotics for mycotoxin biodegradation. Additionally, Dr. Ali explores the role of pathological markers in disease diagnosis and studies the effects of environmental toxins. His research contributions, particularly in advancing molecular and cellular pathology, continue to pave the way for innovative treatments in infectious diseases, oncology, and veterinary medicine. 🧫πŸ§ͺπŸ§‘β€πŸ”¬

Publication Top Notes

  • πŸ“– Microbial and enzymatic battle with food contaminant zearalenone (ZEN) – Cited by: 23 – Year: 2022

  • πŸ“– In-vitro assessment of a novel plant rhizobacterium, Citrobacter freundii, for degrading and biocontrol of food mycotoxin deoxynivalenol – Cited by: 21 – Year: 2023

  • πŸ“– Prevalence, molecular characterization and antibiogram study of Listeria monocytogenes isolated from raw milk and milk products – Cited by: 18 – Year: 2020

  • πŸ“– Probiotics: Helpful for the prevention of COVID-19? – Cited by: 17 – Year: 2020

  • πŸ“– Green nanotechnology mediated silver and iron oxide nanoparticles: Potential antimicrobials – Cited by: 15 – Year: 2022

  • πŸ“– Type I IFNs: a blessing in disguise or partner in crime in MERS-CoV-, SARS-CoV-, and SARS-CoV-2-induced pathology and potential use of type I IFNs in synergism with IFN-Ξ³ – Cited by: 14 – Year: 2021

  • πŸ“– Potassium use efficiency of maize hybrids – Cited by: 12 – Year: 2012

  • πŸ“– Aflatoxins associated oxidative stress and immunological alterations are mitigated by dietary supplementation of Pichia kudriavzevii in broiler chicks – Cited by: 10 – Year: 2021

  • πŸ“– Reply Letter-COVID-19 (Novel Coronavirus 2019)-Recent trends – Cited by: 10 – Year: 2020

  • πŸ“– Potential therapeutic strategies to combat HCC – Cited by: 9 – Year: 2022

  • πŸ“– Role of Streptococci as etiological agents of dental caries – Cited by: 9 – Year: 2020

  • πŸ“– Pollen micromorphology among amaranthaceous species from desert rangeland – Cited by: 8 – Year: 2023

  • πŸ“– Impact of silver dopant on structural, optical and electrical properties of ZnO nanoparticles – Cited by: 8 – Year: 2019

  • πŸ“– The adverse effects of carbofuran are efficiently counteracted by the supplementation of star anise (Illicium verum) in broiler chicks – Cited by: 7 – Year: 2020

  • πŸ“– Mitigative Potential of Novel Lactobacillus plantarum TISTR 2076 against the Aflatoxins-Associated Oxidative Stress and Histopathological Alterations in Liver and Kidney of Broiler Chicks – Cited by: 6 – Year: 2022

Conclusion

Dr. Ashiq Ali’s strong academic background, extensive research experience, and high-impact contributions in pathology and immunology make him a strong candidate for the Best Researcher Award. His expertise in molecular diagnostics, vaccine development, and immunology, coupled with his teaching and mentoring skills, align well with the award’s criteria.

Sharada Mokkapati | Cancer Biology | Best Researcher Award

Published on by Global Academic Awards

Dr. Sharada Mokkapati | Cancer Biology | Best Researcher Award

Dr. Sharada Mokkapati, The UT MD Anderson Cancer Center, United States

Dr. Sharada Mokkapati is an Assistant Professor of Urology (Research) at UT MD Anderson Cancer Center, specializing in oncology, molecular biology, and gene therapy. With a PhD in Genetics from the University of Cologne, Germany (2007), Dr. Mokkapati has contributed significantly to bladder cancer research. She was a key team member in the first FDA-approved gene therapy for bladder cancer and has extensive experience with gene therapy vector development, RNA/DNA molecular techniques, and NextGen sequencing. Her research also includes the identification of miRNA biomarkers and the study of tumor metabolism in gene therapy responses. Dr. Mokkapati has received multiple awards, including the Dodie P. Hawn Fellowship and the Lennox K. Black International prize for excellence in medicine. She is also an adhoc reviewer for journals like BMC Cancer and has co-authored numerous influential publications on bladder cancer and cancer therapy.

Publication Profile

Scopus

Education

Dr. Sharada Mokkapati earned her PhD in Genetics from the University of Cologne, Germany, in February 2007. Her academic journey has focused on genetic research, exploring complex biological systems to understand various genetic disorders. With a robust foundation in genetic principles, she has contributed significantly to the scientific community through research, publications, and collaborations. Dr. Mokkapati’s work has emphasized advancing knowledge in molecular genetics, genetic markers, and hereditary diseases, making a lasting impact on the field. Her dedication continues to inspire the next generation of genetic researchers. πŸŒ±πŸ“š

 

Professional Experience 🌟

Dr. Sharada Mokkapati has an extensive career in academia and research. Since 2020, she has served as an Assistant Professor in Urology (Research) at the UT MD Anderson Cancer Center. Previously, she was an Instructor in Urology (Research) at the same institution from 2015 to 2020. Dr. Mokkapati’s academic journey began with a postdoctoral fellowship in the Department of Genetics at UT MD Anderson Cancer Center (2008-2015). Her early career includes graduate studies in Dermatology at the University of Cologne (2002-2007), and research roles at SPIC Science Foundation and Malladi Drugs & Pharmaceuticals in India. πŸ§¬πŸ”¬

 

 

Research Achievements πŸ§¬πŸ”¬

Dr. Sharada Mokkapati has made significant contributions to the field of oncology and gene therapy. She was a key team member in the development of the first FDA-approved gene therapy for bladder cancer. With extensive experience in oncology, molecular biology, biochemistry, biotechnology, and biomedical research, Dr. Mokkapati has developed and validated vectors for gene therapy. She is highly proficient in RNA, DNA, protein molecular techniques, biochemical assays, and NextGen sequencing. Additionally, Dr. Mokkapati excels in using both xenograft and genetically engineered mouse models for translational biology studies and managing research-related compliance and clinical trial databases. πŸ§ͺπŸ’‘

 

Awards and Honors πŸ…πŸŽ“

Dr. Sharada Mokkapati has been recognized with several prestigious awards throughout her career. She was honored with the “Dodie P. Hawn Fellowship in Genetics” at UT MD Anderson Cancer Center. Dr. Mokkapati also received the “Travel Award-Lennox K. Black International Prize for Excellence in Medicine” for her contribution to the 12th International Symposium on Basement Membranes in Philadelphia. As a team member, she contributed to the technology transfer for amylase and tannase at SPIC Science Foundation, India. Additionally, she qualified the “National Eligibility Test for Lectureship (NET)” and received the “Dr. T. Ramachandra Rao Memorial Gold Medal” for academic excellence in her Master’s studies. πŸ†πŸ§¬

 

 

Research Focus πŸ”¬πŸ’‘

Dr. Sharada Mokkapati’s research primarily focuses on oncology, molecular biology, and gene therapy in the context of bladder cancer. She has contributed extensively to the molecular profiling of bladder cancer, identifying relevant subtypes for biomarker discovery. Her work also includes the development and validation of gene therapy vectors, particularly in non-muscle invasive bladder cancer. Dr. Mokkapati is proficient in RNA/DNA/protein molecular techniques, biochemical analysis, and NextGen sequencing, using mouse models to address both basic biological and translational studies. Her efforts aim to integrate gene therapies into bladder cancer treatment paradigms. 🧬🧫🎯

 

Publication Top Notes

  • Molecular profiling of bladder cancer xenografts defines relevant molecular subtypes and provides a resource for biomarker discovery (2025) – Cited by 0 πŸ”¬πŸ“š
  • Integrating gene therapy into the treatment paradigm for non-muscle invasive bladder cancer (2025) – Cited by 0 πŸ§¬πŸ’‘
  • Concomitant antihistamine administration improves survival outcomes in urothelial carcinoma treated with atezolizumab (2025) – Cited by 0 πŸ’ŠπŸ“ˆ
  • Single-cell RNA sequencing analysis identifies acute changes in the tumor microenvironment induced by interferon Ξ± gene therapy in a murine bladder cancer model (2024) – Cited by 0 πŸ§ͺ🧬
  • Interferon gene therapy with nadofaragene firadenovec for bladder cancer: from bench to approval (2023) – Cited by 7 πŸ₯πŸ”¬
  • The current status of gene therapy in bladder cancer (2023) – Cited by 8 πŸ“–πŸ”
  • Lentiviral interferon: A novel method for gene therapy in bladder cancer (2022) – Cited by 8 🧬πŸ§ͺ
  • Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non-muscle-invasive Bladder Cancer (2022) – Cited by 16 πŸ§ͺπŸ”¬
  • TCF21 promotes luminal-like differentiation and suppresses metastasis in bladder cancer (2020) – Cited by 7 🧬πŸ’₯
  • Generation of a novel mouse strain with conditional, cell-type specific, expression of DND1 (2019) – Cited by 2 πŸπŸ”¬

 

 

 

Hadi Alizadeh | Cancer stem cells | Best Researcher Award

Published on by Global Academic Awards

Mr. Hadi Alizadeh | Cancer stem cells | Best Researcher Award

Graduate Master Student, Tarbiat Modares University, Iran

Mr. Hadi Alizadeh is a Master’s graduate in Molecular Genetics from Tarbiat Modares University, Tehran, with a thesis on AGPAT3 gene and cisplatin resistance in ovarian cancer cells. His research encompasses gene expression analysis, drug discovery, and epigenomic profiling, focusing on chemoresistance mechanisms in cancer. He has contributed to various publications and presented at international conferences. Skilled in PCR, RNA-seq, flow cytometry, and bioinformatics, he is proficient in machine learning and molecular dynamics. Hadi has been recognized for his academic excellence, ranking highly in national exams. He also has hands-on experience in medical genetics and as a teaching assistant. πŸ§¬πŸ’‰πŸ”¬

 

Publication Profile

Orcid

Education

Mr. Hadi Alizadeh completed his Master’s in Molecular Genetics at Tarbiat Modares University, Tehran, from October 2021 to November 2023, achieving an impressive average of 18.2/20. His thesis, titled “Introduction of AGPAT3 gene as a regulator of cisplatin resistance in A2780 ovarian cancer cell line,” was supervised by Dr. Soltani. Prior to this, he earned a Bachelor’s degree in Genetics from Islamic Azad University, North Tehran, from October 2016 to May 2020, with a strong academic performance, securing an average of 17.83/20. His solid educational background highlights his commitment to molecular genetics and cancer research. πŸ“šπŸ§¬

 

Research Experience

Mr. Hadi Alizadeh’s research experience includes significant work in molecular genetics and cancer research. For his Master’s thesis, he explored AGPAT3 gene as a regulator of cisplatin resistance in ovarian cancer cells, performing RNA-seq and various functional assays like RT-qPCR, western blotting, and apoptosis assays, revealing AGPAT3’s role in survival and cell cycle arrest under cisplatin treatment. He also studied the synergistic effect of dendrosomal nano-curcumin (DNC) with cisplatin in reducing cisplatin resistance. Additionally, he worked on epigenomic profiling of oxaliplatin-resistant HCT116 colorectal cancer cells and drug discovery targeting mTORC1 signaling. πŸ§¬πŸ’»

 

Honors & Awards πŸ†πŸŽ“

Mr. Hadi Alizadeh has demonstrated exceptional academic achievements throughout his career. In 2021, he ranked 18th out of nearly 10,000 participants in the national entrance exam for medical genetics in the healthcare system, showcasing his expertise and dedication. Additionally, he secured the 25th position among approximately 7,000 candidates in the national entrance exam for a Master’s program in genetics. These prestigious rankings highlight his strong academic foundation and passion for genetics research, setting the stage for his future contributions to the field. πŸŒŸπŸ“š

 

Professional Experience πŸ’ΌπŸ”¬

Mr. Hadi Alizadeh has gained valuable hands-on experience in various research and clinical settings. As a volunteer at Imam Khomeini Hospital in Tehran, he collected samples and performed RNA extraction for various projects. In his role as an apprentice at the Cytogenetic Lab, he conducted karyotyping as part of clinical genetic analyses, gaining key insights into genetic disorders. Additionally, as a Genetic Laboratory Technician prior to his Master’s, Mr. Alizadeh contributed to the COVID-19 response by performing RNA extraction and real-time PCR on samples, further honing his technical expertise in molecular genetics. πŸ§¬πŸ”¬

 

Research Focus

Mr. Hadi Alizadeh’s research primarily focuses on molecular genetics and cancer biology. His work explores the mechanisms of chemoresistance in cancer, particularly involving the mTORC1 signaling pathway and its role in platinum-based chemotherapy resistance. He also investigates the epigenomic and transcriptomic changes related to chemoresistance in colorectal cancer cells. His expertise extends to drug discovery, with a focus on molecular dynamics and virtual screening for targeting cancer resistance mechanisms. Alizadeh’s research contributes significantly to understanding cancer cell survival and potential therapeutic strategies. πŸ§¬πŸ’‰πŸ’‘

 

Publication Top Notes

  • Introduction of AGPAT3 gene as a regulator of cisplatin resistance in A2780 ovarian cancer
    cell line (under review after revision in PLOS ONE)
  • Β Phosphatidic acid as a cofactor of mTORC1 in platinum-based chemoresistance: Mechanisms
    and therapeutic potential (Review article) (Published)
  • Β Epigenomic and Transcriptomic Profiling of Oxaliplatin Resistant HCT116 Colorectal
    Cancer Cells Reveals Super-Enhancer-Driven Mechanisms of Chemoresistance
    (Bioinformatic article) (Revision in Scientific Reports)
  • Comparison of Machine Learning Algorithms and Feature Selection Methods for Identifying
    Important Features of Expression Data (Manuscript preparation)
  • Bioinformatic Analysis to find drugs Inhibiting mTORC1 as a Phosphatidic AcidDisplacement Strategy (Manuscript preparation)
  • Β Comparison of Signaling Pathways and Genetic Modifications of Cancer Stem Cells with
    Normal Stem Cells (Review article) (ready to submit)

 

 

 

Xiyuan Wang | social psychology | Best Researcher Award

Published on by Global Academic Awards

Xiyuan Wang | social psychology | Best Researcher Award

Professor at Donghua University, China.

Professor Xiyuan Wang is a distinguished academic and researcher in industrial economics and design, affiliated with Donghua University. His expertise extends to advising on industry policy as part of a think tank for the Shanghai Municipal Government and as a key figure in the China Industrial Design Association. With multiple accolades, including national and provincial awards, Professor Wang’s research has significantly influenced China’s industrial and cultural sectors. He has spearheaded numerous research projects, contributing to both academic advancements and policy development, making him a prominent thought leader in industrial design and economic research.

Publication Profile

Scopus

Educational Background

Professor Wang earned his Ph.D. from the ISCTE-University Institute of Lisbon, a premier European institution recognized for its business and social sciences programs. Following his doctorate, he completed a postdoctoral fellowship in industrial economics, allowing him to deepen his understanding of economic frameworks in industrial settings. His education has provided a solid foundation in both theoretical and applied economics, with an emphasis on cross-cultural business research. This academic background has shaped his career and expertise, positioning him as a respected authority in industrial economics and design within academic and industry circles.

Experience

Throughout his career, Professor Wang has held influential roles in academia and industry advisory capacities. As a professor at Donghua University, he has educated and mentored future leaders in industrial economics. Beyond academia, he serves as an expert on the Shanghai Municipal Government’s think tank and is a committee member of the China Industrial Design Association. His responsibilities also include evaluating the Industrial Design discipline for China’s Ministry of Education. These roles highlight his diverse experience and commitment to advancing both academic knowledge and practical applications within China’s industrial landscape.

Research Focus

Professor Wang’s research primarily focuses on industrial economics and the economic impacts of industrial design. His work emphasizes the integration of economic principles with design innovation to promote sustainable industrial growth. He is also involved in researching economic policy for industrial advancement, with a particular interest in the cultural industries. His role as a researcher for the China Institute of Industrial Economics underscores his dedication to studying China’s industrial framework, contributing to policies that shape industry standards. His research contributions have directly impacted China’s approach to industrial and cultural economic development.

Awards and honors

Professor Wang has received numerous awards that underscore his contributions to industrial economics and design. His honors include the prestigious “Cultural Industry Promotion Award” from the Ministry of Culture of China and the “Excellent Research Achievement Award” from the Ministry of Commerce of China. These awards reflect national recognition of his contributions to advancing industrial and cultural sectors through innovative research. He has also been recognized at the provincial and ministerial levels, further affirming his role as a leading figure in industrial research and his influence in shaping policy and academic frameworks in China.

Conclusion

Professor Wang Xiyuan is a strong candidate for the Best Researcher Award, given his outstanding academic credentials, contributions to industrial economics, and influence in both governmental and industrial sectors. His accolades and project leadership reflect his dedication and substantial achievements in the field. With minor enhancements in international engagement and publication reach, Professor Wang could elevate his contributions to even greater heights, further establishing his reputation as a leading researcher in industrial economics and design.

Publication Top Notes

“Exploring the Impact of AI Enhancement on the Sports App Community: Analyzing Human-Computer Interaction and Social Factors Using a Hybrid SEM-ANN Approach”

Authors: Xie, G., Wang, X.

Citation: Xie, G., & Wang, X. (2024). Exploring the impact of AI enhancement on the sports app community: Analyzing human-computer interaction and social factors using a hybrid SEM-ANN approach. International Journal of Human-Computer Interaction.

“Research on the Human-Computer Interaction Interface Design of Intelligent Luggage”

Authors: Wang, X., Yi, X.

Citation: Wang, X., & Yi, X. (2022). Research on the human-computer interaction interface design of intelligent luggage. Journal of Physics: Conference Series, 2337(1), 012019.

“Theoretical Model on Transformation Factors of Scientific and Technological Achievements under the Belt and Road Initiative”

Authors: Wang, X., Zhou, Y., Zhang, Z., Pang, X., Yan, D.

Citation: Wang, X., Zhou, Y., Zhang, Z., Pang, X., & Yan, D. (2021). Theoretical model on transformation factors of scientific and technological achievements under the Belt and Road Initiative. Journal of Donghua University (English Edition), 38(6), 557–568.

“Functional Requirements of FPS Mobile Games Users Based on KANO Model”

Authors: Wang, X., Chen, D., Fu, T.

Citation: Wang, X., Chen, D., & Fu, T. (2021). Functional requirements of FPS mobile games users based on KANO model. Advances in Intelligent Systems and Computing, 1233 AISC, 278–284.

“Information Interface of Artificial Intelligence Medical Device Information”

Authors: Wang, X.Y., Fu, T., Zhang, Y., Yan, D.

Citation: Wang, X.Y., Fu, T., Zhang, Y., & Yan, D. (2020). Information interface of artificial intelligence medical device information. Advances in Intelligent Systems and Computing, 1117 AISC, 1293–1303.

“Comparative Study on Energy Saving of Low-Carbon Materials in Sanitary Ware Development”

Authors: Wang, X.Y.

Citation: Wang, X.Y. (2018). Comparative study on energy saving of low-carbon materials in sanitary ware development. Materials Science Forum, 917 MSF, 289–293.

“Comparative Research on Energy-Saving Performance of New Energy Vehicles”

Authors: Wang, X.Y., Liu, Y.

Citation: Wang, X.Y., & Liu, Y. (2014). Comparative research on energy-saving performance of new energy vehicles. Applied Mechanics and Materials, 602-605, 214–219.

“Study on Circulation Application and Energy-Conservation Management Based on Exhibition Project”

Authors: Wang, X., Xiang, W., Ya’nan, W., Han, J.

Citation: Wang, X., Xiang, W., Ya’nan, W., & Han, J. (2012). Study on circulation application and energy-conservation management based on exhibition project. Applied Mechanics and Materials, 121-126, 2906–2910.

“R&D on Wollastonite-Based Energy-Saving Construction Materials”

Authors: Wang, X., Wu, X., Li, Y.

Citation: Wang, X., Wu, X., & Li, Y. (2011). R&D on wollastonite-based energy-saving construction materials. Applied Mechanics and Materials, 99-100, 1005–1013.

“Study on Comfortability of the Sports Shoes’ Material Interface”

Authors: Wang, X., Wu, X., Han, J.

Citation: Wang, X., Wu, X., & Han, J. (2011). Study on comfortability of the sports shoes’ material interface. Advanced Materials Research, 332-334, 1984–1991.

Sr. Gotfrida Marandu | Breast Cancer | Best Researcher Award

Published on by Global Academic Awards

Sr. Gotfrida Marandu | Breast Cancer | Best Researcher Award

Sr. Gotfrida Marandu at Catholic University of Health and Allied Sciences , Tanzania.

Sr. Gotfrida M. Marandu is a dedicated Tanzanian nurse, educator, and researcher with a career spanning over two decades in healthcare education, administration, and clinical practice. She has held various influential roles, including lecturer and quality assurance officer at CUHAS, where she shapes the next generation of healthcare professionals. Her work spans nursing education, healthcare management, and cancer care, making her an advocate for quality healthcare in Tanzania. Passionate about advancing nursing practices and improving healthcare outcomes, Sr. Gotfrida’s contributions are rooted in her extensive training and commitment to improving healthcare systems and patient support services.

Publication Profile

ORCID

Educational Background

Sr. Gotfrida has a diverse educational background, beginning with a Diploma in Nursing from Huruma School of Nursing. She earned a Bachelor of Science in Nursing from Tumaini University in 2010 and later an MSc in Nursing Education from Kenya Methodist University in 2014. Currently, she is pursuing advanced research in breast cancer at CUHAS (2022-2025). Her education reflects a commitment to deepening her expertise and advancing nursing education, with each academic milestone equipping her with the skills necessary for teaching, curriculum development, and improving healthcare delivery in her community.

Experience

With over 20 years of experience, Sr. Gotfrida has served in numerous capacities, including assistant lecturer, coordinator, and quality assurance officer. She began as a healthcare administrator and HIV/AIDS counselor in Tanzania’s health centers and later transitioned into academic roles at Tanga Nursing School and CUHAS. Her experience includes coordinating programs for midwifery and nursing education, acting as principal of nursing schools, and developing educational frameworks. This extensive experience in both teaching and administration has empowered her to lead healthcare training initiatives, enhancing the quality of nursing education and improving healthcare standards in Tanzania.

Research Focus

Sr. Gotfrida’s current research focus is breast cancer, an area she has been exploring since 2022 through her studies at CUHAS. Her research aims to improve early diagnosis, treatment options, and patient outcomes in cancer care, particularly within resource-limited settings. Her experience in palliative care and counseling for cancer patients further informs her approach, emphasizing compassionate care and patient education. She also explores integrated reproductive health and quality assurance in healthcare, with a particular interest in empowering healthcare providers to deliver competent, respectful maternity and cancer care services.

Awards and honors

Throughout her career, Sr. Gotfrida has been recognized for her contributions to nursing education and healthcare quality improvement. She has been honored with leadership roles, including quality assurance officer and coordinator of various healthcare programs. Her achievements in curriculum development, midwifery training, and healthcare management reflect her commitment to excellence in nursing education. Although specific formal awards are not listed, her influence and respected positions within Tanzanian healthcare institutions highlight her dedication to advancing the nursing profession and improving healthcare outcomes for communities.

Conclusion

Sr. Gotfrida M. Marandu possesses an impressive blend of academic qualifications, practical experience, and extensive training in healthcare education, quality assurance, and nursing management. Her ongoing research on breast cancer and her broad expertise in health systems management make her a strong candidate for a research-focused award. However, she may further strengthen her profile by publishing more research and refining her focus within a specialized area of study. With these improvements, she would be well-positioned to be recognized as a leading researcher in her field.

Publication Top Notes

Title: “Evaluation of Breast Health Promotion Intervention Among Catholic Nuns in Lake Zone, Tanzania”

Citation: “Evaluation of Breast Health Promotion Intervention Among Catholic Nuns in Lake Zone, Tanzania.” European Journal of Breast Health, 2024, doi:10.4274/ejbh.galenos.2024.2024-1-10.

Title: “Factors Associated With Uptake of Breast Cancer Screening Among Catholic Nuns in Lake Zone, Tanzania”

  • Authors: Not specified in the provided information
  • Year: 2024
  • Journal: International Journal of Breast Cancer
  • DOI: 10.1155/2024/5024392
  • Source: Crossref

Citation: “Factors Associated With Uptake of Breast Cancer Screening Among Catholic Nuns in Lake Zone, Tanzania.” International Journal of Breast Cancer, 2024, doi:10.1155/2024/5024392.